# American Shared Hospital Services: financial statements, quarterly

AMS · NYSE · CIK 744825 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ams.md) · [Financials](/companies/ams/financials.md) · [Filings](/companies/ams/filings.md) · [Insiders](/companies/ams/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ams/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,134](/filings/0001437749-24-035251.md) | [5,698 d](/filings/0001437749-25-011052.md) | [5,216](/filings/0001437749-25-017106.md) | [7,056](/filings/0001437749-25-026568.md) | [6,999](/filings/0001437749-26-001452.md) | [9,069 d](/filings/0001437749-26-010731.md) | [6,112](/filings/0001437749-26-017046.md) | [7,071](/filings/0001437749-26-027716.md) | [7,171](/filings/0001437749-26-001452.md) | [7,728 d](/filings/0001437749-26-010731.md) | [7,084](/filings/0001437749-26-017046.md) | [8,430](/filings/0001437749-26-027716.md) |
| Cost of revenue | $k | [3,032](/filings/0001437749-23-031902.md) | [2,882 d](/filings/0001437749-25-011052.md) | [3,073](/filings/0001437749-25-017106.md) | [4,588](/filings/0001437749-25-026568.md) | [5,629](/filings/0001437749-26-001452.md) | [5,865 d](/filings/0001437749-26-010731.md) | [5,170](/filings/0001437749-26-017046.md) | [5,441](/filings/0001437749-26-027716.md) | [5,585](/filings/0001437749-26-001452.md) | [6,822 d](/filings/0001437749-26-010731.md) | [5,796](/filings/0001437749-26-017046.md) | [6,997](/filings/0001437749-26-027716.md) |
| Gross profit | $k | [2,102](/filings/0001437749-24-035251.md) | [2,816 d](/filings/0001437749-25-011052.md) | [2,143](/filings/0001437749-25-017106.md) | [2,468](/filings/0001437749-25-026568.md) | [1,370](/filings/0001437749-26-001452.md) | [3,204 d](/filings/0001437749-26-010731.md) | [942](/filings/0001437749-26-017046.md) | [1,630](/filings/0001437749-26-027716.md) | [1,586](/filings/0001437749-26-001452.md) | [906 d](/filings/0001437749-26-010731.md) | [1,288](/filings/0001437749-26-017046.md) | [1,433](/filings/0001437749-26-027716.md) |
| Selling, general and administrative | $k | [1,735](/filings/0001437749-24-035251.md) | [1,760 d](/filings/0001437749-25-011052.md) | [1,879](/filings/0001437749-25-017106.md) | [1,896](/filings/0001437749-25-026568.md) | [1,923](/filings/0001437749-26-001452.md) | [1,709 d](/filings/0001437749-26-010731.md) | [1,808](/filings/0001437749-26-017046.md) | [1,746](/filings/0001437749-26-027716.md) | [1,538](/filings/0001437749-26-001452.md) | [1,986 d](/filings/0001437749-26-010731.md) | [1,910](/filings/0001437749-26-017046.md) | [2,042](/filings/0001437749-26-027716.md) |
| Operating income | $k | [90.0](/filings/0001437749-24-035251.md) | [407 d](/filings/0001437749-25-011052.md) | [(85.0)](/filings/0001437749-25-017106.md) | [(1.0)](/filings/0001437749-25-026568.md) | [(889)](/filings/0001437749-26-001452.md) | [(1,830) d](/filings/0001437749-26-010731.md) | [(1,299)](/filings/0001437749-26-017046.md) | [(544)](/filings/0001437749-26-027716.md) | [(344)](/filings/0001437749-26-001452.md) | [(1,401) d](/filings/0001437749-26-010731.md) | [(924)](/filings/0001437749-26-017046.md) | [(910)](/filings/0001437749-26-027716.md) |
| Interest expense | $k | [277](/filings/0001437749-24-035251.md) | [287 d](/filings/0001437749-25-011052.md) | [349](/filings/0001437749-25-017106.md) | [385](/filings/0001437749-25-026568.md) | [336](/filings/0001437749-26-001452.md) | [429 d](/filings/0001437749-26-010731.md) | [433](/filings/0001437749-26-017046.md) | [428](/filings/0001437749-26-027716.md) | [392](/filings/0001437749-26-001452.md) | [321 d](/filings/0001437749-26-010731.md) | [302](/filings/0001437749-26-017046.md) | [301](/filings/0001437749-26-027716.md) |
| Income tax | $k | [60.0](/filings/0001437749-24-035251.md) | [338 d](/filings/0001437749-25-011052.md) | [(44.0)](/filings/0001437749-25-017106.md) | [(31.0)](/filings/0001437749-25-026568.md) | [(169)](/filings/0001437749-26-001452.md) | [(51.0) d](/filings/0001437749-26-010731.md) | [(323)](/filings/0001437749-26-017046.md) | [(21.0)](/filings/0001437749-26-027716.md) | [48.0](/filings/0001437749-26-001452.md) | [(197) d](/filings/0001437749-26-010731.md) | [92.0](/filings/0001437749-26-017046.md) | [135](/filings/0001437749-26-027716.md) |
| Net income | $k | [118](/filings/0001437749-24-035251.md) | [415 d](/filings/0001437749-25-011052.md) | [119](/filings/0001437749-25-017106.md) | [3,602](/filings/0001437749-25-026568.md) | [(207)](/filings/0001437749-26-001452.md) | [(1,328) d](/filings/0001437749-26-010731.md) | [(625)](/filings/0001437749-26-017046.md) | [(280)](/filings/0001437749-26-027716.md) | [(17.0)](/filings/0001437749-26-001452.md) | [(631) d](/filings/0001437749-26-010731.md) | [(612)](/filings/0001437749-26-017046.md) | [(514)](/filings/0001437749-26-027716.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001437749-24-035251.md) | not reported | [0.02](/filings/0001437749-25-017106.md) | [0.55](/filings/0001437749-25-026568.md) | [(0.03)](/filings/0001437749-26-001452.md) | not reported | [(0.10)](/filings/0001437749-26-017046.md) | [(0.04)](/filings/0001437749-26-027716.md) | [0.00](/filings/0001437749-26-001452.md) | not reported | [(0.09)](/filings/0001437749-26-017046.md) | [(0.07)](/filings/0001437749-26-027716.md) |
| Basic EPS | $ per share | [0.02](/filings/0001437749-24-035251.md) | not reported | [0.02](/filings/0001437749-25-017106.md) | [0.56](/filings/0001437749-25-026568.md) | [(0.03)](/filings/0001437749-26-001452.md) | not reported | [(0.10)](/filings/0001437749-26-017046.md) | [(0.04)](/filings/0001437749-26-027716.md) | [0.00](/filings/0001437749-26-001452.md) | not reported | [(0.09)](/filings/0001437749-26-017046.md) | [(0.07)](/filings/0001437749-26-027716.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.5](/filings/0001437749-24-035251.md) | [13.7](/filings/0001437749-25-011052.md) | [12.8](/filings/0001437749-25-017106.md) | [14.2](/filings/0001437749-25-026568.md) | [13.8](/filings/0001437749-26-001452.md) | [11.0](/filings/0001437749-26-010731.md) | [11.2](/filings/0001437749-26-017046.md) | [11.1](/filings/0001437749-26-027716.md) | [5.1](/filings/0001437749-26-001452.md) | [3.5](/filings/0001437749-26-027716.md) | [5.0](/filings/0001437749-26-017046.md) | [6.5](/filings/0001437749-26-027716.md) |
| Current assets | $m | [20.4](/filings/0001437749-23-031902.md) | [20.5](/filings/0001437749-25-011052.md) | [21.4](/filings/0001437749-24-017104.md) | [25.6](/filings/0001437749-24-026762.md) | [25.7](/filings/0001437749-24-035251.md) | [26.3](/filings/0001437749-26-010731.md) | [23.7](/filings/0001437749-25-017106.md) | [24.4](/filings/0001437749-25-026568.md) | [20.6](/filings/0001437749-26-001452.md) | [17.7](/filings/0001437749-26-027716.md) | [18.3](/filings/0001437749-26-017046.md) | [17.4](/filings/0001437749-26-027716.md) |
| Total assets | $m | [47.4](/filings/0001437749-23-031902.md) | [48.2](/filings/0001437749-25-011052.md) | [50.1](/filings/0001437749-24-017104.md) | [60.8](/filings/0001437749-24-026762.md) | [63.3](/filings/0001437749-24-035251.md) | [60.2](/filings/0001437749-26-010731.md) | [63.3](/filings/0001437749-25-017106.md) | [63.5](/filings/0001437749-25-026568.md) | [59.6](/filings/0001437749-26-001452.md) | [55.5](/filings/0001437749-26-027716.md) | [54.7](/filings/0001437749-26-017046.md) | [52.5](/filings/0001437749-26-027716.md) |
| Current liabilities | $m | [10.0](/filings/0001437749-23-031902.md) | [10.8](/filings/0001437749-25-011052.md) | [10.8](/filings/0001437749-24-017104.md) | [13.3](/filings/0001437749-24-026762.md) | [17.6](/filings/0001437749-24-035251.md) | [10.4](/filings/0001437749-26-010731.md) | [12.7](/filings/0001437749-25-017106.md) | [20.9](/filings/0001437749-25-026568.md) | [25.8](/filings/0001437749-26-001452.md) | [23.4](/filings/0001437749-26-027716.md) | [23.7](/filings/0001437749-26-017046.md) | [22.4](/filings/0001437749-26-027716.md) |
| Total liabilities | $m | [21.4](/filings/0001437749-23-031902.md) | [21.9](/filings/0001437749-25-011052.md) | [23.7](/filings/0001437749-24-017104.md) | [28.5](/filings/0001437749-24-026762.md) | [31.4](/filings/0001437749-24-035251.md) | [30.2](/filings/0001437749-26-010731.md) | [34.1](/filings/0001437749-25-017106.md) | [34.6](/filings/0001437749-25-026568.md) | [31.0](/filings/0001437749-26-001452.md) | [27.8](/filings/0001437749-26-027716.md) | [28.0](/filings/0001437749-26-017046.md) | [26.7](/filings/0001437749-26-027716.md) |
| Long-term debt | $m | [10.5](/filings/0001437749-23-031902.md) | [11.0](/filings/0001437749-25-011052.md) | [12.9](/filings/0001437749-24-017104.md) | [12.1](/filings/0001437749-24-026762.md) | [10.8](/filings/0001437749-24-035251.md) | [17.3](/filings/0001437749-26-010731.md) | [16.8](/filings/0001437749-25-017106.md) | [9.2](/filings/0001437749-25-026568.md) | [0.0](/filings/0001437749-26-001452.md) | [0.0](/filings/0001437749-26-010731.md) | [16.8](/filings/0001437749-26-017046.md) | [16.2](/filings/0001437749-26-027716.md) |
| Current portion of debt | $m | [1.5](/filings/0001437749-23-031902.md) | [2.1](/filings/0001437749-25-011052.md) | [2.7](/filings/0001437749-24-017104.md) | [3.0](/filings/0001437749-24-026762.md) | [3.6](/filings/0001437749-24-035251.md) | [2.8](/filings/0001437749-26-010731.md) | [3.1](/filings/0001437749-25-017106.md) | [9.9](/filings/0001437749-25-026568.md) | [18.2](/filings/0001437749-26-001452.md) | [17.3](/filings/0001437749-26-027716.md) | [16.8](/filings/0001437749-26-017046.md) | [16.2](/filings/0001437749-26-027716.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [22.1](/filings/0001437749-23-031902.md) | [22.6](/filings/0001437749-25-011052.md) | [22.8](/filings/0001437749-24-017104.md) | [26.5](/filings/0001437749-24-026762.md) | [26.4](/filings/0001437749-24-035251.md) | [25.2](/filings/0001437749-26-010731.md) | [24.6](/filings/0001437749-25-017106.md) | [24.5](/filings/0001437749-25-026568.md) | [24.6](/filings/0001437749-26-001452.md) | [24.0](/filings/0001437749-26-027716.md) | [23.5](/filings/0001437749-26-017046.md) | [23.1](/filings/0001437749-26-027716.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,564 d](/filings/0001437749-24-035251.md) | [(3,060) d](/filings/0001437749-25-011052.md) | [(1,865)](/filings/0001437749-25-017106.md) | [1,286 d](/filings/0001437749-25-026568.md) | [472 d](/filings/0001437749-26-001452.md) | [274 d](/filings/0001437749-26-010731.md) | [2,503](/filings/0001437749-26-017046.md) | [(372) d](/filings/0001437749-26-027716.md) | [1,671 d](/filings/0001437749-26-001452.md) | [(704) d](/filings/0001437749-26-010731.md) | [2,149](/filings/0001437749-26-017046.md) | [2,236 d](/filings/0001437749-26-027716.md) |
| Capital expenditure | $k | [3,615 d](/filings/0001437749-24-035251.md) | [97.0 d](/filings/0001437749-25-011052.md) | [1,183](/filings/0001437749-25-017106.md) | [1,216 d](/filings/0001437749-25-026568.md) | [879 d](/filings/0001437749-26-001452.md) | [4,660 d](/filings/0001437749-26-010731.md) | [4,015](/filings/0001437749-26-017046.md) | [1,901 d](/filings/0001437749-26-027716.md) | [3,702 d](/filings/0001437749-26-001452.md) | [(1,984) d](/filings/0001437749-26-010731.md) | [41.0](/filings/0001437749-26-017046.md) | [58.0 d](/filings/0001437749-26-027716.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,273](/filings/0001437749-23-031902.md) | [6,472](/filings/0001437749-24-017104.md) | [6,336](/filings/0001437749-24-026762.md) | [6,432](/filings/0001437749-24-035251.md) | [6,576](/filings/0001437749-25-017106.md) | [6,583](/filings/0001437749-25-026568.md) | [6,482](/filings/0001437749-26-001452.md) | [6,572](/filings/0001437749-26-017046.md) | [6,582](/filings/0001437749-26-027716.md) | [6,632](/filings/0001437749-26-001452.md) | [6,725](/filings/0001437749-26-017046.md) | [6,872](/filings/0001437749-26-027716.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,650,000 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027716.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.